Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Screening Europe

Lorenz Mayr's Biography

Lorenz Mayr, Vice President, AstraZeneca Ltd

Lorenz is working as Vice President, Reagents & Assay Development with global responsibility for generation of biological reagents and assay development activities at AstraZeneca. This includes generation of proteins and cell lines for hit finding, hit-to-lead and lead optimisation activities including structure & biophysics for all therapeutic areas, generation of tool antibodies, transgenic animals, stem/primary cells as tools for target validation and lead optimisation. His department is responsible for the development of biochemical, cell-based and phenotypic assays at AstraZeneca.
Before that, he was working as Executive Director at Novartis in Basel/Switzerland, at Bayer in Leverkusen & Wuppertal/Germany and at the MIT/Whitehead Institute in Cambridge/MA (U.S.A.).
He has published more than 50 papers in peer-reviewed journals and serves on several editorial and scientific advisory boards, including two terms at the Board of Directors for SBS (2004-2011) and has been working as the Conference Chair of the MipTec Conference, Europe’s largest drug discovery event.

Lorenz Mayr Image

Precise Genome Editing and Stem Cell Technologies - Novel Tools for Novel Medicines

Wednesday, 18 February 2015 at 11:00

Add to Calendar ▼2015-02-18 11:00:002015-02-18 12:00:00Europe/LondonPrecise Genome Editing and Stem Cell Technologies - Novel Tools for Novel Medicines Screening Europe in Berlin, GermanyBerlin,

This presentation will describe the use of cell lines derived from human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) for drug discovery at AstraZeneca.

Add to Calendar ▼2015-02-17 00:00:002015-02-18 00:00:00Europe/LondonScreening EuropeScreening Europe in Berlin, GermanyBerlin,